DPP-4i extends the half-life of GLP-1, thereby enhancing insulin production and diminishing glucagon release, which leads to improved glycemic control in individuals with type 2 diabetes mellitus (T2DM) [9]. Here, GLP1R is linked to type 2 diabetes mellitus.